Clinical Trial Update: LifeVest Post-CABG Registry

View source ↗

Summary

A Zoll LifeVest post-CABG registry was terminated; the update provides no efficacy or safety results in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Ischemia
• Sudden Cardiac Death
• Ventricular Dysfunction
• Ventricular Fibrillation
• Ventricular Tachycardia

Snippet

Sponsor: Zoll Medical Corporation | Conditions: Sudden Cardiac Death, Ventricular Fibrillation | Status: TERMINATED